Certara (CERT) vs Marqeta (MQ)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Certara (CERT) has outperformed Marqeta (MQ) over the past year, gaining 22.1% versus a loss of 14.3%. Over five years, CERT leads with a -62.2% price change compared with -81.6% for MQ. Marqeta is the larger company by market cap ($1.69 billion vs $1.61 billion), about 1.0 times the size.
On valuation, Certara trades at a lower forward P/E (27.0x vs 32.8x for Marqeta). Certara converts more of its revenue into profit, with a net margin of -0.4% versus -2.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | MQ |
|---|---|---|
| Share price | $10.55 | $16.24 |
| Market cap | $1.61B | $1.69B |
| 1-day change | -1.22% | -1.16% |
| YTD return | +19.75% | -14.53% |
| 1-year return | +22.11% | -14.35% |
| 5-year return | -62.19% | -81.59% |
| P/E ratio (TTM) | — | 13.31 |
| Forward P/E | 26.96 | 32.81 |
| EPS (TTM) | $-0.18 | $1.22 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $418.84M | $624.88M |
| Revenue growth (YoY) | +8.75% | +23.25% |
| Net income (latest FY) | $-1.59M | $-13.93M |
| Gross margin | 61.53% | 69.98% |
| Operating margin | 5.02% | -7.43% |
| Net margin | -0.38% | -2.23% |
| 52-week high | $12.61 | $20.56 |
| 52-week low | $4.45 | $14.80 |
| Distance from 52-week high | -16.34% | -21.01% |
| Analyst consensus | buy | hold |
| Avg. price target upside | +20.19% | +27.96% |
| Average volume | 2.61M | 806.85K |
| Shares outstanding | 152.54M | 96.01M |
| Employees | 1,515 | 938 |
| Sector | Technology | Technology |
| Industry | Computer Software: Prepackaged Software | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CERT has outperformed MQ by 36.5 percentage points over the past year.
- Marqeta grew revenue faster in its latest fiscal year (+23.25% vs +8.75%).
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Technology · Computer Software: Prepackaged Software · 1,515 employees
About Marqeta
MQ stock →Marqeta, Inc. operates a cloud-based open API platform for card issuing and transaction processing services in the United States.
Technology · Computer Software: Prepackaged Software · 938 employees
CERT vs MQ FAQ
Which is bigger, Certara or Marqeta?
Marqeta (MQ) is larger, with a market capitalization of $1.69B compared with $1.61B for Certara (CERT).
Which stock has performed better over the past year, CERT or MQ?
CERT returned +22.11% over the past 12 months, compared with -14.35% for MQ (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Marqeta in the same industry?
Yes. Both are classified in the Computer Software: Prepackaged Software industry within the Technology sector.